(Q52920858)

9 May 2018

title

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. (English)

1 reference

9 May 2018

1 reference

8

1 reference

9 May 2018

Christoph Röcken

9

1 reference

9 May 2018

Manfred Dietel

7

object named as

Manfred Dietel

1 reference

9 May 2018

Wilko Weichert

1

object named as

Wilko Weichert

1 reference

9 May 2018

author name string

Annika Röske

2

1 reference

9 May 2018

Volker Gekeler

3

1 reference

9 May 2018

Thomas Beckers

4

1 reference

9 May 2018

Matthias P A Ebert

5

1 reference

9 May 2018

Matthias Pross

6

1 reference

9 May 2018

publication date

1 February 2008

1 reference

9 May 2018

Lancet Oncology Commission

published in

1 reference

9 May 2018

volume

9

1 reference

9 May 2018

page(s)

139-148

1 reference

9 May 2018

issue

2

1 reference

9 May 2018

Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Gastric cancer: epidemiology, pathology and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Histone Acetylation and Gastrointestinal Carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Epigenetic therapy of cancer: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Histone deacetylase inhibitors: molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Increased expression of histone deacetylase 2 is found in human gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

Molecular-pathological prognostic factors of gastric cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970004-4

7 January 2021

10.1016/S1470-2045(08)70004-4

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

18207460

1 reference

9 May 2018